VIB4920
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for VIB4920, covering 2023-02-14 to 2025-12-19. Get the full timeline:
Most recent: Clinical Trial Update: VIBRANT: VIB4920 for Active Lupus Nephritis [Phase 2]